Podcasts about Major depressive disorder

Why does your brain feel like it's working against you when you're depressed? In this episode, licensed marriage and family therapist Kati Morton answers deep viewer questions to unpack what is actively happening in the body and brain during depressive episodes and periods of suicidal ideation. We challenge the traditional "chemical imbalance" framework to look at the modern science of mental health: how different regions of the brain communicate, why your HPA axis can get stuck in a chronic stress response, and the clinical data pointing to systemic inflammation as a primary driver of depressive symptoms. Plus, Kati breaks down the absolute differences between clinical depression, situational sadness, grief, and passive vs. active suicidal thoughts. What We Cover: The DSM-5 Checklist: The 9 diagnostic criteria for Major Depressive Disorder. The Serotonin Myth: Why modern psychiatric research is moving away from looking at single chemical levels. The Inflammation Connection: Active clinical trials utilizing anti-inflammatory pathways to treat mental health. Your Audio Action Plan: How to implement behavioral activation, circadian light exposure protocols, and cognitive tools to stop internal negative loops. Special Thanks to Our Sponsor: Go to hellorebound.com/AskKatiAnything to check your insurance or get matched with a virtual trauma specialist today. Real, evidence-based trauma treatment is within reach. If you are in immediate danger or experiencing a mental health crisis, please call or text 988 (US) or contact the Crisis Text Line by texting HOME to 741741. In the UK, you can reach the Samaritans at 116 123. You do not have to fight this alone. Learn more about your ad choices. Visit megaphone.fm/adchoices

Most of us are doing all the things — and still not feeling vital and energized. This episode might reveal the missing piece…   In this week's episode, I sit down with Connie Zack, co-founder of Sunlighten Saunas, and her story alone is worth pressing play for. It starts with someone she loves, a health crisis that wouldn't budge, and a discovery that quietly changed the direction of her life.   We get into what infrared light actually is — and why it's so much more than just a hot room. We cover how it works at the cellular level, and what that actually means for detox, circulation, and the kind of deep rest most of us aren't getting. We also had a really honest conversation about the nervous system — why you genuinely cannot heal when you're stuck in fight-or-flight, and what it actually takes to come back into regulation.   It's not about adding another step to your wellness routine. It's about understanding what your body needs to do what it is innately designed to do... to heal.   If you feel like you've been running on empty and can't quite figure out why… I think this conversation is going to open something up for you. If you follow me on Instagram, you know how obsessed I am with my infrared sauna. It's my mini oasis where I go to replenish and reflect. If you'd like to learn more or create your own sauna tailored to your needs, visit Sunlighten.com/healwithkelly to receive a personalized quote. Infrared saunas can be pricey — so it's a great time to remind you that the sun is the most abundant and free source of infrared light. Spending 10–15 minutes outdoors in the morning or late afternoon will also give you a healthy dose of rich spectrum near-infrared rays. LINKS Sunlighten website: https://www.sunlighten.com/ Sunlighten on Instagram @sunlightensaunas Connie Zack on Instagram @conniejozack Go to Sunlighten.com/healwithkelly to get your personalized quote. Key Moments You'll Love ✨ : ☀️ [0:00] Her Brother's Mercury Poisoning and the Sauna That Saved Him

Send us Fan MailEvening Prayer (Eternal, Infinite, Holy Unchanging All Knowing all Powerful God; Major Depressive disorder, Bipolar, Schizophrenia; Prison Ministry; Rest Well) #pray #prayer #Christianprayer #Christian #Jesus Thank you for listening, our heart's prayer is for you and I to walk daily with Jesus, our joy and peaceaimingforjesus.comYouTube Channel https://www.youtube.com/@aimingforjesus5346Instagram https://www.instagram.com/aiming_for_jesus/Threads https://www.threads.com/@aiming_for_jesusX https://x.com/AimingForJesusTik Tok https://www.tiktok.com/@aiming.for.jesus

Disrupted patterns in our brain waves, particularly the balance of gamma and beta waves, has been observed in ADHD, schizophrenia, Bipolar disorder, autism, Alzheimer's dementia, Major Depressive Disorder, Parkinson's disease and Huntington's motor disease. These conditions share malfunction in the brain's 'drum section', the parvalbumin interneurons, which seem to set the rhythm for gamma waves. Dissociative Identity Disorder reveals disruption in brain wave patterns, but the malfunction seems to be more regionally specific and caused by changes in signaling from the brain's 'band conductor', the somatostatin interneurons. This suggests that rational function, 'consciousness', relates to our having steady brain waves, which are coordinated across functional regions of the brain in order for us to 'pay attention' or make rational decisions, or simply stay awake and alert.Nutrient support and avoiding some dietary chemicals can help improve the balanced signaling that we need for improved functioning. Rhythmic exercise or listening to synchronizing music or frequencies, while avoiding chaotic or desynchronizing rhythms may also be a direct help, supporting dysfunctional parvalbumin interneurons that may no longer be 'playing a steady beat'.Calming or helps detox: Electrolytes: magnesium and adequate potassium and sodium without an excess of calcium supplementation; Amino acid support: glycine, Dimethylglycine, serine, taurine; Avoid excess glutamate which is common in food seasonings (MSG and many others) and it is naturally rich in tomatoes and cheese.B-vitamins: methyl folate (not in excess, 400 mcg) and B12, thiamine, riboflavin, niacin, choline, pyridoxine, pantothenic acid, and betaine may be needed for some, but my own gene differences mean I need glycine/DMG, and avoid excess betaine (also called TMG, tri-methyl glycine).Rhythmic exercise and sunshine help normalize brain waves and support mitochondrial function. Problems with mitochondria are linked to disruption in cognitive and physical health and problems with the somatostatin and parvalbumin cells. Disclaimer: This information is being shared for educational purposes within the guidelines of Fair Use and is not intended to provide individual health care guidance. This podcast episode was unscripted--I think the information is important to share . I plan to add a link with supporting references later.

Dr. Jason Tucciarone and Dr. Alan Schatzberg (Stanford University, Stanford, CA) join AJP Audio to discuss the use of low-dose buprenorphine as an adjunctive therapy to extend the anti-suicidal effects of ketamine treatment in patients with major depressive disorder and suicidal ideation.  AJP Editor-in-Chief Dr. Ned Kalin joins to discuss the rest of the June issue of the Journal, which takes a close look at issues surrounding suicide and severe depression. 01:20     Tucciarone and Schatzberg interview 03:36     Disparity between effects on suicidal ideation and antidepressant ratings 05:36     Ethics of placebo and ketamine in patients with suicidal ideation 08:28     Immediate clinical implications 11:40     Limitations 14:10     Further research 16:19     Kalin interview 16:24     Tucciarone et al. 20:39     Rovers et al. 24:30     Jelen et al. Transcript Board-certified psychiatrists, if you're seeking meaningful inpatient work with real clinical autonomy, consider becoming the Clinical Director for a 16-bed behavioral health hospital in Fergus Falls or Bemidji, Minnesota. You'll lead a supportive interdisciplinary team, enjoy predictable work-life balance, and have opportunities for teaching and mentorship without RVU pressure or third-party billing. Learn more on APA's Career Center, JobCentral, by searching Direct Care and Treatment – State of Minnesota. Direct Care and Treatment – State of Minnesota:  bit.ly/DCTClinicalDirector Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it. Subscribe to the podcast here. Listen to other podcasts produced by the American Psychiatric Association. Browse articles online. How authors may submit their work. Follow the journals of APA Publishing on Twitter. E-mail us at ajp@psych.org

Laughing in the Dark: Suicide Prevention, Comedy, and Hope with Frank King In this episode, Kevin sits down with Frank King, a suicide prevention speaker, comedian, and former writer for The Tonight Show. Frank spent 20 years writing for late night television and has been a full time speaker and comedian for more than 40 years. Frank's work is deeply personal. His speaking is shaped by his lifelong experience with Major Depressive Disorder and Chronic Suicidal Ideation, including moments where he came close enough to ending his life that he can speak honestly and powerfully about what that darkness feels like. Instead of hiding that story, Frank has turned his long, dark journey of the soul into lifesaving work. He has delivered 13 TEDx Talks and shares his insights with corporations, associations, and audiences across the country to help people understand suicide prevention, mental health, and the power of honest conversation. Over the course of his career, Frank has shared the stage with legendary comedians and entertainers including Jeff Foxworthy, Adam Sandler, Jerry Seinfeld, Dr. Ken Jeong, Ellen DeGeneres, Dennis Miller, Lou Rawls, The Beach Boys, and Randy Travis. And somehow, on top of all that, Frank has survived two aortic valve replacements, a double bypass, a heart attack, and losing to a puppet on the original Star Search. And yes, he's lived to joke about it all. This conversation is honest, meaningful, surprisingly funny, and deeply human. Frank brings a rare mix of comedy, courage, and lived experience to one of the most important conversations we can have. In This Episode Kevin and Frank talk about: • Suicide prevention and mental health • Living with Major Depressive Disorder • Chronic Suicidal Ideation • Why humor can help open hard conversations • Turning pain into purpose • Frank's journey as a comedian, speaker, and TEDx presenter • What people often misunderstand about suicidal thoughts • How honest conversations can save lives About Frank King Frank King is a suicide prevention speaker, comedian, and former writer for The Tonight Show. He has been a full time speaker and comedian for 40 years and has delivered 13 TEDx Talks. His work is informed by his lived experience with Major Depressive Disorder and Chronic Suicidal Ideation, and he now uses comedy and storytelling to help organizations have lifesaving conversations around mental health and suicide prevention.

Indiana has a theory for why Richard Allen confessed to the Delphi murders while sitting in solitary confinement at Westville. According to the State's appellate brief, Richard Allen found religion in his cell. He had a spiritual awakening. He decided to come clean.What the defense has documented is something else entirely. A man who lost 45 pounds in solitary. A man who tore up his legal mail. A man who ate his Bible. A man who drank from the toilet. A man who asked his own father, on a recorded phone call, how much longer he was going to be lucid. A man whose Major Depressive Disorder was documented before he ever entered Westville — and whose decline was so visible that the defense team described him as psychotic and gravely disabled.The Indiana Department of Correction's own written policy says inmates with serious mental illness cannot be kept in solitary for more than 30 days. Allen was kept there for 13 months.Defense attorney Bob Motta joins Tony Brueski for Part Two of a three-part panel on the Richard Allen appeal. They put the State's religious-conversion narrative next to the contemporaneous medical and behavioral record. They walk through what an appellate panel actually does when a confession is extracted from a man in that condition. They examine the institutional knowledge the State had before placing Allen in solitary, the policy the State broke by holding him there, and the confession the State is now trying to protect.Three judges at the Court of Appeals are reading both stories. Only one of them is going to survive review.LINKS:Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodDISCLAIMER:This publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.HASHTAGS:#RichardAllen #DelphiMurders #DelphiAppeal #ReligiousConversion #BobMotta #TrueCrimeToday #AbbyAndLibby #SolitaryConfinement #CoercedConfession #TrueCrime

Richard Allen walked into Westville Correctional Facility weighing 180 pounds. By April 2023, he weighed 135 pounds. He had been in solitary confinement the entire time. He was not under sentence. He had not yet been to trial. He was a pretrial detainee in a maximum-security prison's most restrictive housing — and the documented evidence is that he was losing his mind.He tore up his legal mail. He drank from the toilet. He ate his Bible. He hit his head against the cell door. He asked his own father, on a phone call, how much longer he could stay lucid. And then he confessed to the Delphi murders.The Indiana Department of Correction has a written policy. Inmates with serious mental illness — and Allen had a documented diagnosis of Major Depressive Disorder before he ever arrived at Westville — cannot be held in solitary for more than 30 days. Richard Allen was held there for 13 months. The Indiana Attorney General is now asking three judges at the Court of Appeals to call all of that constitutionally fine.Defense attorney Bob Motta joins Tony Brueski for Part Two of a three-part panel on the Richard Allen appeal. They walk through what the documented decline at Westville actually looked like in real time. They examine the religious-conversion theory the State has offered to explain why Allen confessed, and they put it next to the contemporaneous behavioral record. They get into the jailhouse calls — one heard by the jury, two excluded — and what selective admission of evidence around a confession does to the voluntariness question three judges now have to answer.The State broke its own rule by more than twelve months. Three judges are reading.LINKS:Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodDISCLAIMER:This publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.HASHTAGS:#RichardAllen #DelphiMurders #DelphiAppeal #SolitaryConfinement #Westville #BobMotta #HiddenKillers #AbbyAndLibby #IndianaDepartmentOfCorrection #TrueCrime

According to Richard Allen's appellate brief, the Indiana Department of Correction knew. They knew that solitary confinement could worsen Allen's Major Depressive Disorder. They knew it could cause psychosis. Their own written policy restricts inmates with serious mental illness to 30 days in solitary for exactly that reason.They held Richard Allen in solitary for 13 months.By April 2023, the man who would later confess to the Delphi murders weighed 45 pounds less than when he arrived at Westville. He was, in the defense's own words, gravely disabled. He was eating his Bible. He was drinking from the toilet. He was asking his own father how much longer he could stay lucid.The Indiana Attorney General now argues that none of this rises to coercion. The State offered a religious-conversion theory to explain Allen's confessions instead. The defense has documented a psychiatric collapse.Defense attorney Bob Motta joins Tony Brueski for Part Two of a three-part panel on the Delphi appeal. They sit with the institutional knowledge the State had before it ever put Richard Allen in that cell, and the decision the State made to leave him there anyway. They get into what an appeals court does when a state agency violates its own written rule by more than a year and then asks a panel of judges to call the resulting confession voluntary. They walk through the religious-conversion narrative the State is selling and the medical record sitting underneath it.Three judges. Indiana's own rulebook. The State's own warning. A pretrial detainee who lost his mind in a cell he was never supposed to be in.LINKS:Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodDISCLAIMER:This publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.HASHTAGS:#RichardAllen #DelphiMurders #DelphiAppeal #SolitaryConfinement #Psychosis #BobMotta #HiddenKillers #AbbyAndLibby #IndianaDepartmentOfCorrection #TrueCrime

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.This episode covers interventional psychiatry with Dr. Sean Nestor, an interventional psychiatrist and clinician-scientist at the University of Toronto, where he serves as Assistant Director of the Psychiatry Program and oversees the Clinician Researcher Track (CResT) residency within the Department of Psychiatry. His research program at Sunnybrook Health Sciences Centre focuses on advancing the clinical application of neuromodulation therapies to improve outcomes across a wide range of psychiatric disorders.The learning objectives for this episode are as followsDefine interventional psychiatry and distinguish it from traditional pharmacologic and psychotherapy-based approachesDescribe the role of interventional psychiatry in clinical practice, including identifying patient populations most likely to benefit from neuromodulation treatmentIdentify pathways to become involved in research and scholarly work within the field of interventional psychiatryGuest: Dr. Sean NestorHosts: Dr. Pooja Sankar (PGY1), Michael Wang (MS4), Dr. Kate BraithwaiteAudio editing: Dr. Kate BraithwaiteTime Stamps:(2:25) - Defining Interventional Psychiatry (IP) and its role in Psychiatric practice(4:20) - Evolution of Interventional Psychiatry (IP)(8:40) - Patients who will benefit from IP modalities(12:35) - Other factors to consider when assessing a patient for IP (15:30) - rTMS(19:15) - Description of a typical rTMS session(23:50) - ECT(26:45) - Ketamine(29:05) - Other Investigational Modalities(30:45) - Maintenance treatment(35:30) - Medication and IP(37:55) - Addressing stigma of ECT(43:15) - Discussion on place of IP in Depression management decision tree(47:00) - How to get involved in IP(50:10) - Rewarding aspects of working in IP(52:25) - Challenges of working in IP(53:40) - Future of the field Resources:⁠Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) | Stanford Health Care⁠⁠CTMSS | International medical society dedicated to optimizing clinical practice, supporting research, and increasing access to high quality, evidence-based Transcranial Magnetic Stimulation⁠The Interventional Psychiatry Consortium⁠References:Andrade, J. & Brito, M.. (2023). When the SAINT goes marching in – A novel transcranial magnetic stimulation protocol shows miraculous promise. European Psychiatry. 66. S835-S835. 10.1192/j.eurpsy.2023.1768. ⁠Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults | CANMAT⁠Conway, C. R., & Sackeim, H. A. (2022). Interventional Psychiatry: The revolution has arrived. Brazilian Journal of Psychiatry. ⁠https://doi.org/10.47626/1516-4446-2022-0046⁠ Rakesh, G., Cordero, P., Khanal, R., Himelhoch, S. S., & Rush, C. R. (2024). Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis. Journal of affective disorders, 358, 432–439. https://doi.org/10.1016/j.jad.2024.05.037Yavi, M., Lee, H., Henter, I. D., Park, L. T., & Zarate, C. A., Jr (2022). Ketamine treatment for depression: a review. Discover mental health, 2(1), 9. ⁠https://doi.org/10.1007/s44192-022-00012-3⁠Zaidi, A., Shami, R., Sewell, I. J., Cao, X., Giacobbe, P., Rabin, J. S., Goubran, M., Hamani, C., Swardfager, W., Davidson, B., Lipsman, N., & Nestor, S. M. (2024). Antidepressant class and concurrent rTMS outcomes in major depressive disorder: a systematic review and meta-analysis. EClinicalMedicine, 75, 102760. https://doi.org/10.1016/j.eclinm.2024.102760 For more PsychEd, follow us on Instagram (⁠⁠⁠@psyched.podcast⁠⁠⁠), Facebook (⁠⁠⁠PsychEd Podcast⁠⁠⁠), X (⁠⁠⁠@psychedpodcast⁠⁠⁠), and Bluesky (⁠⁠⁠@psychedpodcast.bsky.social⁠⁠⁠). You can email us at ⁠⁠⁠psychedpodcast@gmail.com⁠⁠⁠ and visit our website at⁠⁠⁠ psychedpodcast.org⁠⁠⁠

Explore how rapid-acting therapies transform major depressive disorder (MDD) care--uncover the neurobiology and mechanisms driving faster antidepressant effects. Credit available for this activity expires: [04/27/27] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/mechanisms-behind-rapid-acting-treatments-major-depressive-2026a1000cld?ecd=bdc_podcast_libsyn_mscpedu

On this earth we are going to experience pain. We are going to have hard times. It is what allows us to know what the joy and sweet is. Today I am talking about the difference between sadness and Major Depression.  An Episode I did on a fear of trials My Church's Suicide Prevention Site Emotional Resilience Book I have been Referring to (IT'S FREE!) Link to Negative Emotions Class Email me: positivityinpregnancy@gmail.com Website: www.positivityinpregnancy.com MENTAL HEALTH MINI VIDEOS for pregnancy: What once made up my ‘Morning Sickness Mini Course for Mental Health' is now divided into individual videos(and each video comes with the audio) that you can now buy individually instead of purchasing the whole course! Discover a beautiful collection of short, heartwarming positivity videos (ranging from 1–8 minutes) thoughtfully designed to nurture your mind, body, and spirit throughout pregnancy. Each video focuses on one of four powerful pillars:  Mental Health (to support emotional well-being),  Pregnancy Affirmations (that uplift and empower),  Gratitude practices (that fill your heart with joy),   And simple yet transformative ways to shift negative thoughts into positive light (These gentle reminders celebrate the incredible journey you're on).  Here is the link to all the videos: https://pregnancyishard.com/collections/all I recommend starting with the Mental Health section!  Visit My Pregnancy Week-by-Week Page:https://pregnancyishard.com/pages/week-by-week-pregnancy Here is the Facebook Page for Pregnancy is hard: I have documented my journey of my fourth baby on this page and have other juicy and good tips for enjoying pregnancy better. https://www.facebook.com/pregnancyishard Here is the Pregnancy is Hard Support Group on Facebook: Let's offer support, help and fun for those in the trenches of pregnancy! https://www.facebook.com/groups/165102315544693 YouTube for Positivity in Pregnancy: https://www.youtube.com/@PregnancyisHardwithJosly-nd8wd Instagram: @positivityinpregnancy My Side Candle Business: Flickers Candle Co www.flickerscandleco.com  

This week, Emily welcomes Kyrus Keenan Westcott, the creator behind The Vibe with Ky. Ky is an ADHD/neurodiversity advocate, host, and theatrical director who uses his massive platform to validate the neurodivergent experience with humor and radical honesty. In this episode, Ky opens up about his ADHD diagnosis at age 34 and the subsequent journey through anger, mourning, and eventual acceptance. They talk about the fluctuating capacity of the ADHD brain, why we can build a website in a day but struggle to get off the couch the next, and why the Western 9-to-5 ideology often fails neurodivergent people. From managing Delayed Sleep Phase Syndrome to the true definition of introversion, this conversation is all about giving yourself grace as you navigate a world that wasn't built for your brain. TAKEAWAYS Adult diagnosis often triggers a transition from anger and mourning to self-forgiveness. Task initiation is a neurological barrier, not a character flaw, and understanding the chemical basis of ADHD helps dismantle the "lazy" label. Neurodivergent fluctuating capacity means your best effort looks different from one day to the next, based on environment, health, and brain chemistry. Introversion is defined by energy replenishment and selectivity, not shyness. An introvert can be the "belle of the ball" when the topic and environment align with their interests. Environmental hacks, like keeping your phone out of the bedroom, can serve as a physical bridge to overcome task initiation struggles in the morning. Mental health professionals, join us for our upcoming training, Interpreting Autism Assessment Data in High-Masking and Under-Identified Presentations. Dr. Taylor Day is the presenter, and it will be held Friday, April 3 at 2:00 PM Eastern. If you can't make it live, the recorded self-study version will be available shortly after the live event. It's approved for both APA and NBCC continuing ed hours. You can register here. Kyrus Keenan Westcott is a content creator, mental health advocate, and digital marketing strategist based in the Greater Philadelphia area. He is the founder of The Vibe With Ky, a digital platform that uses humor, honesty, and real-life storytelling to make conversations about ADHD, anxiety, and mental health more approachable and relatable. Diagnosed in adulthood with ADHD (Inattentive Type), Major Depressive Disorder, and Generalized Anxiety Disorder, Kyrus blends lived experience with a refreshingly candid voice, offering validation without toxic positivity. Outside of his advocacy work, he's a Senior Paid Media Strategist with over 20 years of experience and an accomplished theater performer and director. Whether he's creating viral content or chasing a 3 AM burst of inspiration, Kyrus is all about keeping it real and helping others feel seen. BACKGROUND READING Ky's website, Instagram, Tiktok, Facebook, YouTube, Ky's most popular video The Neurodiversity Podcast is on Facebook, Instagram, BlueSky, and you're invited to join our Facebook Group. For more information go to www.NeurodiversityPodcast.com. If you'd like members of your organization, school district, or company to know more about the subjects discussed on our podcast, Emily Kircher-Morris provides keynote addresses, workshops, and training sessions worldwide, in-person or virtually. You can choose from a list of established presentations, or work with Emily to develop a custom talk to fit your unique situation. To learn more, visit our website.

On this edition of The Mark White Show, we're focusing on two major health issues affecting millions of Americans: colorectal cancer and major depressive disorder. In our first segment, Dr. James T. McCormick, DO, FACS, of the American College of Surgeons, discusses the rising rates of colorectal cancer in adults under 50. He explains which symptoms should never be ignored, why delays in diagnosis are common among younger patients, and when screening should begin. Early detection can save lives, and this conversation highlights why awareness matters at every age. In our second segment, we turn to mental health. Depression affects an estimated 21 million adults in the United States, and many individuals with Major Depressive Disorder continue to experience symptoms even while in treatment. Dr. Saundra Jain, MA, PsyD, LPC, and mental health advocate Kelly Uchima share insights into the evolving treatment landscape, the importance of integrated care, and how emerging, technology-supported tools are designed to complement traditional approaches. Listen & share. It could save someone's life.

Psychedelics are having a cultural moment. Research is promising. Stories of healing are everywhere. But here's the truth: these experiences aren't magic cures. And they aren't right for every nervous system at every time.   In this episode, Elisabeth Kristof and Jennifer Wallace slow the conversation down. Instead of asking, "Do psychedelics heal trauma?" They explore a more grounded question: What becomes possible when psychedelic or peak somatic experiences are approached through the lens of nervous system safety, preparation, and integration?   If you've been curious about psychedelics, already had experiences, or feel unsure whether they're right for you, this episode offers nuance, research, and deep nervous system perspective. Because post-traumatic growth isn't about becoming someone new. It's about becoming more available to the life that's already waiting for you.   Topic Covered Why psychedelics may reorganize meaning, not just reduce symptoms How trauma fragments narrative and how safety allows integration The science of psychological flexibility and why it predicts long-term outcomes What "somatic journeying" is and why it can feel disorienting The importance of preparation, titration, and facilitator trust Why intensity does not equal healing Psychedelics vs antidepressants in research on connectedness Default Mode Network (DMN), identity rigidity, and belief updating Why creativity often emerges when survival softens The risks of over-reliance and "chasing the medicine" Why discernment and self-trust matter more than hype   Chapters  00:00 – Psychedelics Aren't Magic Cures
 03:00 – Meaning-Making & Narrative Reorganization
 08:58 – Psychological Flexibility & Emotional Capacity
 17:00 – Preparation, Somatic Journeying & Integration
 23:29 – Connectedness & Relational Repair
 34:33 – Identity, Neuro Tags & the Default Mode Network
 41:03 – Creativity as a Byproduct of Safety
 48:14 – Discernment, Industry Hype & Self-Trust   Calls to Action: Neurosomatic Intelligence is now enrolling : https://neurosomaticintelligence.com/nsi-certification Sacred Synapse: an educational YouTube channel founded by Jennifer Wallace that explores nervous system regulation, applied neuroscience, consciousness, and psychedelic preparation and integration through Neurosomatic Intelligence.    Wayfinder Journal: Track nervous system patterns and support preparation and integration through Neurosomatic Intelligence.   FREE 1 Year Supply of Vitamin D + 5 Travel Packs from Athletic Greens when you use my exclusive offer: https://www.drinkag1.com/rewired  Learn to work with Boundaries at the level of the body and nervous system at https://www.boundaryrewire.com Get a two-week free trial of neurosomatic training at https://rewiretrial.com Sources:    Amada, N., et al. "The Transformative Potential of Psychedelic Experiences: A Qualitative Analysis of Meaning-Making and Narrative Reorganization." Journal of Consciousness Studies, vol. 27, no. 7–8, 2020, pp. 122–150.   Carhart-Harris, Robin L., et al. "Neural Correlates of the Psychedelic State as Determined by fMRI Studies with Psilocybin." Proceedings of the National Academy of Sciences, vol. 109, no. 6, 2012, pp. 2138–2143.   Carhart-Harris, Robin L., et al. "The Entropic Brain: A Theory of Conscious States Informed by Neuroimaging Research with Psychedelic Drugs." Frontiers in Human Neuroscience, vol. 8, 2014, article 20.   Carhart-Harris, Robin L., et al. "Psilocybin with Psychological Support for Treatment-Resistant Depression: Six-Month Follow-Up." Psychopharmacology, vol. 235, no. 2, 2018, pp. 399–408.   Davis, Alan K., Roland R. Griffiths, and Frederick S. Barrett. "Psychological Flexibility Mediates the Relations between Acute Psychedelic Effects and Subjective Decreases in Depression and Anxiety." Journal of Contextual Behavioral Science, vol. 15, 2020, pp. 39–45.   Davis, Alan K., et al. "Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial." JAMA Psychiatry, vol. 78, no. 5, 2021, pp. 481–489.   Erritzoe, David, et al. "Effects of Psilocybin Therapy versus Escitalopram on Depression and Emotional Connectedness in Major Depressive Disorder." The New England Journal of Medicine, vol. 384, 2021, pp. 1402–1411.   Griffiths, Roland R., et al. "Psilocybin Produces Substantial and Sustained Decreases in Depression and Anxiety in Patients with Life-Threatening Cancer: A Randomized Double-Blind Trial." Journal of Psychopharmacology, vol. 30, no. 12, 2016, pp. 1181–1197.   MacLean, Katherine A., Matthew W. Johnson, and Roland R. Griffiths. "Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness." Journal of Psychopharmacology, vol. 25, no. 11, 2011, pp. 1453–1461.   Watts, Rosalind, et al. "Patients' Accounts of Increased 'Connectedness' and 'Acceptance' after Psilocybin for Treatment-Resistant Depression." Journal of Humanistic Psychology, vol. 57, no. 5, 2017, pp. 520–564.   Weiss, B., et al. "Associations between Naturalistic Psychedelic Use, Psychological Insight, and Changes in Social Connectedness and Personality." Frontiers in Psychology, vol. 12, 2021, article 667987. Disclaimer: Trauma Rewired podcast is intended to educate and inform but does not constitute medical, psychological or other professional advice or services. Always consult a qualified medical professional about your specific circumstances before making any decisions based on what you hear. We share our experiences, explore trauma, physical reactions, mental health and disease. If you become distressed by our content, please stop listening and seek professional support when needed. Do not continue to listen if the conversations are having a negative impact on your health and well-being. If you or someone you know is struggling with their mental health, or in mental health crisis and you are in the United States you can 988 Suicide and Crisis Lifeline.   If someone's life is in danger, immediately call 911.   We do our best to stay current in research, but older episodes are always available. We don't warrant or guarantee that this podcast contains complete, accurate or up-to-date information. It's very important to talk to a medical professional about your individual needs, as we aren't responsible for any actions you take based on the information you hear in this podcast.   We invite guests onto the podcast. Please note that we don't verify the accuracy of their statements. Our organization does not endorse third-party content and the views of our guests do not necessarily represent the views of our organization. We talk about general neuro-science and nervous system health, but you are unique. These are conversations for a wide audience. They are general recommendations and you are always advised to seek personal care for your unique outputs, trauma and needs.   We are not doctors or licensed medical professionals. We are certified neuro-somatic practitioners and nervous system health/embodiment coaches. We are not your doctor or medical professional and do not know you and your unique nervous system. This podcast is not a replacement for working with a professional. The BrainBased.com site and RewireTrial.com is a membership site for general nervous system health, somatic processing and stress processing. It is not a substitute for medical care or the appropriate solution for anyone in a mental health crisis.   Any examples mentioned in this podcast are for illustration purposes only. If they are based on real events, names have been changed to protect the identities of those involved.   We've done our best to ensure our podcast respects the intellectual property rights of others, however if you have an issue with our content, please let us know by emailing us at traumarewired@gmail.com. All rights in our content are reserved.

When does sadness become a disease? Grief? Dr. Roger McFillin sits down with Mary Ann Kenny a lecturer, a mother of two, and the author of The Episode: A True Story of Loss, Madness and Healing. Ten years ago, her husband went out for a morning run and never came home. What followed was grief—and then a collision with a psychiatric system that would change her life in ways she never could have anticipated. Visit Center for Integrated Behavioral HealthDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here

 According to research presented at the Psychedelic Science 2025 conference in Denver, patients who had been diagnosed with major depressive disorder experienced a dramatic decrease in depression after just one dose of psilocybin (magic mushrooms). Author and psychotherapist Anjalia McGoldrick are living proof of the power of plant-based psychedelics. “Having started her journey as a teen mother, facing significant challenges, navigating life on her own from an early age. Despite these obstacles, she has transformed adversity into a source of strength, cultivating the hope and courage necessary to break cycles of poverty, confront abuse, and realize her dreams.Her unwavering resilience and drive have made Anjalia not only a respected counselor but also an empathetic advocate who intimately understands the struggles her clients face. Never forgetting the trials of her own past, she channels her compassion and love for humanity into every aspect of her work, inspiring and uplifting those who are determined to overcome their own hardships.Anjalia was born in Cincinnati, Ohio, raised in Detroit, Michigan, and now lives in the beautiful Blue Ridge Mountains of Christiansburg, Virginia, with her husband, Tom.She is     the author of The Child I Left Behind: A Mother's Journey Toward Healing & Forgiveness. https://www.anjaliamcgoldrick.com/http://www.yourlotandparcel.org

Depression, also known as major depressive disorder, is projected to be the number 1 cause of disease burden by 2030. We look at the causes and risk factors, the DSM 5 diagnostic criteria, and the treatment of depression.PDFs available here: https://rhesusmedicine.com/pages/psychiatryConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Patreon: https://www.patreon.com/rhesusmedicineBuy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 Major Depressive Disorder0:23 DSM 5 Criteria - Major Depressive Disorder 1:58 Depression Causes & Risk Factors 3:10 Depression Pathophysiology 4:28 Depression Epidemiology 4:59 Depression Diagnosis 5:39 Depression Treatment LINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/Reference:Bains, N. & Abdijadid, S., 2023. Major Depressive Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. [online] Available at: https://www.ncbi.nlm.nih.gov/books/NBK559078/. NCBIPsycom, 2025. DSM-5 depression criteria – Major Depressive Disorder. [online] Available at: https://www.psycom.net/depression/major-depressive-disorder/dsm-5-depression-criteria.Wikipedia, 2025. Major depressive disorder. [online] Available at: https://en.wikipedia.org/wiki/Major_depressive_disorder.National Institute of Mental Health (NIMH), 2025. Depression. [online] Available at: https://www.nimh.nih.gov/health/topics/depression.Bondy, B., 2002. Pathophysiology of depression and mechanisms of treatment. Dialogues in Clinical Neuroscience, 4(1), pp.7–20. [online] Available at: https://www.tandfonline.com/doi/full/10.31887/DCNS.2002.4.1/bbondy. Taylor & Francis OnlineDisclaimer: Please remember this podcast and all content from Rhesus Medicine is for educational and entertainment purposes only and is not a guide to diagnose or to treat any form of condition. The content is not to be used to guide clinical practice and is not medical advice. Please consult a healthcare professional for medical advice.

What's the optimal amount and type of exercise to improve symptoms of Major Depressive Disorder?A new Bayesian network meta-analysis may have the most straightforward answer yet. In this episode, I break down a comprehensive review comparing four primary exercise modalities: aerobic, resistance, mind–body, and mixed training, and their impact on clinically diagnosed MDD.We explore:• The U-shaped dose–response curve• The minimum clinically effective dose (~320 MET-min/week)• The optimal dose (~860 MET-min/week)• Why mind–body training works at a lower volume• How METs standardise intensity across exercise types• How to build an evidence-aligned movement plan when motivation and energy are lowThis is a practical, grounded, science-backed guide to using exercise as one part of a broader approach to healing depression.

On average, you have over 6,000 thoughts a day. That's a lot – and about 80 percent of them are negative. Unsettling thoughts, lingering feelings of sadness or losing interest in activities you once enjoyed are all reasons to check in on your mental health with a trusted friend or your clinician.  If you're looking for options because something feels off or you know a loved one who is facing depression, you'll want to listen to the latest episode of The Healthiest You podcast. In Part One of our podcast series on major depression, you'll hear from psychiatrist Samantha Cerimele, MD, with Lehigh Valley Health Network, part of Jefferson Health. How can you break the cycle of negative thoughts? What causes depression? Which symptoms should not be ignored? Should you try transcranial magnetic stimulation (TMS) therapy? Can St. John's wort supplements help fight depression? We answer these questions and more on The Healthiest You podcast this month.Chapters:0:01 - Intro1:06 - Why women have a higher risk2:16 - What causes depression2:31 - Most common types of depression3:04 - Symptoms you should not ignore 4:33 - Take these first steps if you have symptoms5:35 - How depression is diagnosed6:16 - Treatment options7:15 - Nonmedication treatment options7:33 - Transcranial magnetic stimulation (TMS)8:49 - Side effects of TMS9:14 - Cognitive behavioral therapy (CBT) or talk therapy10:19 - Mental health toolkit11:39 - What to do when your thoughts are spiraling12:16 - Breathing exercise14:29 - St. John's wort supplement

Dr. Suresh Durgam (Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, NJ) joins AJP Audio to discuss a phase 3 randomized controlled trial looking at the use of the antipsychotic medication lumateperone as adjunctive to antidepressant therapy in the treatment of patients with major depressive disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the December issue of the Journal. 00:48   Durgam interview 03:09   Mechanism of action 04:44   Patient-reported outcomes 06:31   Immediate clinical implications 07:32   Limitations 08:08   Further research 09:25   Kalin interview 09:38   Durgam et al. 13:09   Lin et al. 17:22   Brodsky et al. Transcript Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it. Subscribe to the podcast here. Listen to other podcasts produced by the American Psychiatric Association. Browse articles online. How authors may submit their work. Follow the journals of APA Publishing on Twitter. E-mail us at ajp@psych.org

CME credits: 0.50 Valid until: 07-11-2026 Claim your CME credit at https://reachmd.com/programs/cme/updates-in-major-depressive-disorder-with-insomnia/36556/ Approximately 75% to 90% of patients with depression experience insomnia. This means that a very significant portion of individuals struggling with depression also have difficulty sleeping. Join Drs. Michael Thase and Andrew Krystal for this expert discussion to learn about the most recent data presented at the Psych Congress 2025 in San Diego on emerging therapies, such as the selective OX2R antagonists to treat major depressive disorder with insomnia. =

In this episode Rotem Petranker, PhD joins to discuss the current state of research on microdosing psilocybin. Dr. Petranker is the co-founder of the Psychedelic Studies Research Program at the University of Toronto and the Canadian Centre for Psychedelic Science. He recently ran the world's largest randomized controlled trial on the effectiveness of microdosing psilocybin on Major Depressive Disorder. In this conversation, Dr. Petranker shares insights from running the world's largest randomized controlled trial on psilocybin microdosing for major depressive disorder. He explains the origins of microdosing research, from early anecdotes and surveys to his team's carefully designed clinical study comparing psilocybin to placebo across different environments. While participants in both groups reported significant improvements, the findings point to the powerful role of expectancy and placebo effects, alongside nuanced signals of cognitive shifts on measures like dysfunctional attitudes. Dr. Petranker emphasizes the importance of rigorous methodology, open science, and transparency in psychedelic research, while also acknowledging the stories of participants whose lives were positively impacted by study participation itself.   In this episode, you'll hear: What early microdosing research suggested, and its limitations in anecdotal and survey-based designs Why psilocybin was chosen over LSD for the study design  What motivates people to try microdosing a psychedelic Key results from Dr. Petranker's study, including reports of both positive and adverse events How placebo effects—and simply being part of a trial—can powerfully shape outcomes Reflections on how psychedelics may work by increasing connectedness   Quotes: “There's no real rigorous definition [of microdosing]. People say, ‘oh, I'm just going to microdose some mushrooms,' and then they often take a random amount. I think what people mean is ‘I'm going to take an amount that will not knock me out, won't cause serious hallucinations,' but they still use an amount that they often feel. Now, this is in contrast to what people in the [academic] literature define it as, which is more like a sub-perceptual dose, a sub-hallucinogenic dose.” [2:17] “If you microdose and go to work, just to sit under the flickering lights for eight hours in your cubicle versus, say, if you're going to microdose and then go on a walk, or do art, or do as you wish because it's the weekend, you're going to have very different impacts on your anxiety.” [15:26] “[In our study] there were three other self-report measures of depression. There is only a significant difference on one of them, where people who were microdosing were doing better. And that was on the dysfunctional attitude scale, which measures more cognitive assumptions about life.” [26:2] “people who microdose—regardless of why they microdose—they more or less all said that they got to what they wanted through an increased sense of meaning.” [35:05]   Links: Psychedelic Studies Research Program at the University of Toronto Canadian Centre for Psychedelic Science website Canadian Centre for Psychedelic Science on X Canadian Centre for Psychedelic Science on Instagram Previous episode: Microdosing and the Placebo Effect with Balazs Szigeti, PhD Previous episode: James Fadiman answers your Microdosing Questions! Psychedelic Medicine Association Porangui  

Send us a textTriple-board certified psychologist Dr. Heather Luing joins Dr. Erich Schramm to talk about depression. Major depressive disorder affects one in five Americans and ranks among the most disabling conditions worldwide. In spite of this, treatments for depression can be unsatisfying or ineffective for up to 1/3 of patients. The doctors discuss the symptoms, treatments, and biological underpinnings of depression. They move to advances in medications and devices and the possibilities that clinical trials hold for the not-too-distant future, including non-medical solutions like Transcranial Magnetic Stimulation and Vagus Nerve Stimulation for medication-resistant patients.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode covers the basics of electroconvulsive therapy.Hosts: Ravi Bhindi (CC3), Dr. Angad Singh (PGY2)Audio Editing: Dr. Angad Singh (PGY2)Show Notes: Dr. Angad Singh (PGY2)Time Stamps:(0:36) - What is ECT?(2:18) - Indications and efficacy(4:35) - Treatment course(4:32) - Combination treatment(6:33) - Medications to discontinue(8:16) - Contraindications(9:40) - Side effects(11:52) - Procedure(16:03) - SummaryResources:https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/electroconvulsive-therapyhttps://sunnybrook.ca/content/?page=psychiatry-electroconvulsive-therapy-ect-faqReferences:Andrade, C., Arumugham, S. S., & Thirthalli, J. (2016). Adverse Effects of Electroconvulsive Therapy. The Psychiatric clinics of North America, 39(3), 513–530.Brakemeier, E. L., Merkl, A., Wilbertz, G., Quante, A., Regen, F., Bührsch, N., van Hall, F., Kischkel, E., Danker-Hopfe, H., Anghelescu, I., Heuser, I., Kathmann, N., & Bajbouj, M. (2014). Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial. Biological psychiatry, 76(3), 194–202.Espinoza, R. T., & Kellner, C. H. (2022). Electroconvulsive therapy. New England Journal of Medicine, 386(7), 667-672.Gill, S., Hussain, S., Purushothaman, S., Sarma, S., Weiss, A., Chamoli, S., ... & Loo, C. K. (2023). Prescribing electroconvulsive therapy for depression: Not as simple as it used to be. Australian & New Zealand Journal of Psychiatry, 57(9), 1202-1207.Janjua, A. U., Dhingra, A. L., Greenberg, R., & McDonald, W. M. (2020). The efficacy and safety of concomitant psychotropic medication and electroconvulsive therapy (ECT). CNS Drugs, 34(5), 509-520.Jelovac, A., Kolshus, E., & McLoughlin, D. M. (2013). Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 38(12), 2467–2474.Kolshus, E., Jelovac, A., & McLoughlin, D. M. (2017). Bitemporal v. high-dose right unilateral electroconvulsive therapy for depression: a systematic review and meta-analysis of randomized controlled trials. Psychological Medicine, 47(3), 518-530.Lam, R. W., Kennedy, S. H., Adams, C., Bahji, A., Beaulieu, S., Bhat, V., ... & Milev, R. V. (2024). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023: Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. The Canadian Journal of Psychiatry, 69(9), 641-687.Luchini, F., Medda, P., Mariani, M. G., Mauri, M., Toni, C., & Perugi, G. (2015). Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response. World journal of psychiatry, 5(2), 182–192.Tess, A. V., & Smetana, G. W. (2009). Medical evaluation of patients undergoing electroconvulsive therapy. New England Journal of Medicine, 360(14), 1437-1444.Zolezzi M. (2016). Medication management during electroconvulsant therapy. Neuropsychiatric disease and treatment, 12, 931–939.For more PsychEd, follow us on Instagram (@psyched.podcast),  Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social‬). You can email us at psychedpodcast@gmail.com and visit our website at psychedpodcast.org.

This powerful episode of Sh!t That Goes On In Our Heads brings you the raw, honest, and resilient story of Jennifer Ginty—entrepreneur, mental health advocate, and founder of My Moody Monster. Jen lives with Complex PTSD and Major Depressive Disorder stemming from childhood trauma, and she shares how she finally faced her emotional pain, built a healing team, and created tools to help kids and adults express emotions in healthy ways. We are proud to share that our podcast is the 2024 People's Choice Podcast Award Winner for Health and the 2024 Women in Podcasting Award Winner for Best Mental Health Podcast—with over 2 million downloads worldwide. Please help us continue to grow and improve: leave your feedback (written or as a voice message) at https://castfeedback.com/67521f0bde0b101c7b10442a. Mental Health Quote of the Episode "Control isn't necessary for life. You don't need control to live a happy, healthy life." – Jennifer Ginty   What You'll Hear in This Episode In this episode, Jennifer opens up about years of postponing her healing journey, confronting her abuser, and navigating the deep emotional weight of trauma, motherhood, and identity loss. We explore: What triggered her decision to heal finally Her experience with inpatient care and Dialectical Behavioral Therapy (DBT) Creating My Moody Monster, a tool for emotional regulation How generational trauma and people-pleasing behaviors held her back Raising children with mental health challenges The importance of creating a personalized support team SEO Keywords: trauma recovery, emotional healing, PTSD, mental health podcast, childhood trauma, therapy journey, DBT, emotional regulation, parenting mental health, My Moody Monster, coping skills for kids, mental wellness, breaking the stigma, women's mental health   Meet Jennifer Ginty Jennifer is the founder of My Moody Monster, a therapeutic plush toy designed to help children express emotions through physical play. Diagnosed with Complex PTSD and Major Depressive Disorder, Jennifer built a support team, embraced inpatient therapy at McLean Hospital, and now shares her story to help others begin their healing. She also hosts the When Not Yet Becomes Right Now podcast—born from the realization that the right time to heal is now. Website: https://www.mymoodymonster.com Instagram: https://www.instagram.com/mymoodymonster/ Facebook: https://www.facebook.com/mymoodymonster BlueSky: @mymoodymonster.bsky.social YouTube: https://www.youtube.com/@mymoodymonster TikTok: http://www.tiktok.com/@mymoodymonster   Key Takeaways Healing takes readiness, not permission — It's okay to say “not yet,” until your mind says “right now.” Coping skills must be practiced before you need them — Just like muscles, emotional regulation tools require repetition. Kids need emotional tools too — Jennifer's My Moody Monster is a creative, tactile way to help children express and understand emotions.   Actionable Tools DBT (Dialectical Behavioral Therapy) — Focus on mindfulness, emotional regulation, interpersonal effectiveness, and distress tolerance. Build your therapy team — Don't settle for the wrong therapist. Speed-date until you find the right fit. Coping Skill Tools — Try frozen washcloths, modeling clay with essential oils, or tools like My Moody Monster to interrupt intense emotional spirals.   Chapters & Time Stamps [00:00] Intro: Welcome to our award-winning show [01:10] Jennifer's journey begins – Trauma, college, and “not yet” moments [02:57] The breaking point: Bankruptcy, identity loss, and finally saying “right now” [06:38] Confronting her abuser and community shame [10:09] Motherhood and mental health—her son's early suicidal ideation [15:57] Barriers to mental health care access and insurance frustrations [20:52] DBT & McLean Hospital: Building her mental health toolkit [26:05] Real-time coping tools (box breathing, frozen towels, modeling clay) [30:22] The birth of Moody: Creating an emotional outlet [34:06] The love letter: Why Moody is a symbol of hope and self-compassion [36:51] Learning to accept love and let go of control [40:37] Bonus Questions: Her anxiety theme song, tattoos, and the word she hates   References & Mentions McLean Hospital – Premier mental health hospital: https://www.mcleanhospital.org/ DBT Therapy Overview: https://www.psychologytoday.com/us/therapy-types/dialectical-behavior-therapy Crayola Model Magic Clay – Great tactile tool: https://shop.crayola.com/modeling/model-magic My Moody Monster: https://www.mymoodymonster.com Subscribe, Rate, and Review! Enjoying Sh!t That Goes On In Our Heads? Be sure to subscribe, rate, and review on your favorite podcast platform. Your feedback fuels our mission. You can also leave us a message at: https://castfeedback.com/67521f0bde0b101c7b10442a Visit our website: https://goesoninourheads.net/add-your-podcast-reviews Let's continue breaking the silence around mental health—together. #MentalHealthPodcast #MentalHealthAwareness #TraumaHealing #CPTSDRecovery #MyMoodyMonster #ParentingAndMentalHealth #MentalHealthMatters #EmotionalRegulation #DBTskills #HealingJourney #ChildhoodTrauma #MentalHealthSupport #TalkAboutIt #InvisibleIllness #ComplexPTSD #WomenInPodcasting #TherapyIsCool #MentalHealthForMoms #Podmatch #Grex #DirtySkittles ***************************************************************************If You Need Support, Reach OutIf you or someone you know is facing mental health challenges, please don't hesitate to reach out to a crisis hotline in your area. Remember, it's OK not to be OK—talking to someone can make all the difference.United States: Call or Text 988 — 988lifeline.orgCanada: Call or Text 988 — 988.caWorldwide: Find a HelplineMental Health Resources and Tools: The Help HubStay Connected with G-Rex and Dirty SkittlesOfficial Website: goesoninourheads.netFacebook: @shltthatgoesoninourheadsInstagram: @grex_and_dirtyskittlesLinkedIn: G-Rex and Dirty SkittlesJoin Our Newsletter: Sign Up HereMerch Store: goesoninourheads.shopAudio Editing by NJz Audio

Dr. Reedy welcomes Dr. Alexa Altman where she discusses how psychedelics bring the unconscious material into consciousness. She talks about the importance of integration. Dr. Altman's Website: https://www.i-psychedelic.com 1. Single-dose psilocybin (25 mg) with psychological support for MDDJAMA – “Single-Dose Psilocybin Treatment for Major Depressive Disorder” psychiatryonline.org+15sunstonetherapies.com+15pmc.ncbi.nlm.nih.gov+15 Summary: Demonstrated strong antidepressant effects and good tolerability over follow-up. Email: info@hopkinspsychedelic.org 2. One-Year Follow-Up of Psilocybin for Depression Study: Long-term effects of psilocybin therapy for depression Johns Hopkins – “Psilocybin treatment for major depression effective for up to a year” Summary: 67% of participants remained in remission one year post-treatment. 3. MDMA-Assisted Therapy for Severe PTSD Randomized, placebo-controlled MDMA-assisted therapy Nature Medicine – “MDMA-assisted therapy for severe PTSD” Summary: Significant reduction in PTSD symptoms, well‑tolerated in a diverse cohort. Contact (MAPS / Lykos Therapeutics): Email: info@maps.org 4. Psilocybin for Cancer-Related Anxiety & Depression Psilocybin in patients with life-threatening cancer PMC – “High-dose psilocybin produced large decreases in depressed mood and anxiety…” Summary: 80% of participants maintained significant symptom relief at 6 months. Website: heffter.org (contact via site) en.wikipedia.org 1. Johns Hopkins University Center for Psychedelic and Consciousness Research Psilocybin for depression, anxiety, addiction, and end-of-life distress Why it's top-tier: The first major U.S. institution to receive regulatory approval for psychedelic research in modern times.

Join Therapy in a Nutshell's membership and get instant access to all 10 life-changing courses, live weekly Q&As, and a supportive community for just $27/month. Learn how to manage anxiety, process trauma, regulate emotions, and build lasting resilience. Take small, powerful steps toward healing and a richer, more meaningful life. Start your journey today! https://courses.therapyinanutshell.com/membership A lot of people who end up with Major Depressive Disorder have no idea why they feel the way they do. Some have experienced trauma or a huge stressor, but a surprising amount of them say something like, “Everything in my life is fine. I have no reason to be depressed. But I just don't feel happy anymore.” Here's my theory: depression happens when tiny things, often unnoticed, add up over time and become overwhelming. Researchers have explored the brain's “giving up” circuit, which flips from “This is hard, but I'm going to keep trying” to “This is pointless. I'm going to give up.” When life feels too overwhelming, the nervous system reinforces shutdown and hopelessness. This is actually great news because if we can manage just a few of these tiny things, we can remove some of the weight fueling our depression, allowing your brain and body's natural resilience to kick back in. So let's take a look at the micro habits that add up over time to cause depression. Looking for affordable online counseling? My sponsor, BetterHelp, connects you to a licensed professional from the comfort of your own home. Try it now for 10% off your first month: https://betterhelp.com/therapyinanutshell Learn more in one of my in-depth mental health courses: https://courses.therapyinanutshell.com Support my mission on Patreon: https://www.patreon.com/therapyinanutshell Sign up for my newsletter: https://www.therapyinanutshell.com Check out my favorite self-help books: https://kit.co/TherapyinaNutshell/best-self-help-books  Therapy in a Nutshell and the information provided by Emma McAdam are solely intended for informational and entertainment purposes and are not a substitute for advice, diagnosis, or treatment regarding medical or mental health conditions. Although Emma McAdam is a licensed marriage and family therapist, the views expressed on this site or any related content should not be taken for medical or psychiatric advice. Always consult your physician before making any decisions related to your physical or mental health. In therapy I use a combination of Acceptance and Commitment Therapy, Systems Theory, positive psychology, and a bio-psycho-social approach to treating mental illness and other challenges we all face in life. The ideas from my videos are frequently adapted from multiple sources. Many of them come from Acceptance and Commitment Therapy, especially the work of Steven Hayes, Jason Luoma, and Russ Harris. The sections on stress and the mind-body connection derive from the work of Stephen Porges (the Polyvagal theory), Peter Levine (Somatic Experiencing) Francine Shapiro (EMDR), and Bessel Van Der Kolk. I also rely heavily on the work of the Arbinger Institute for my overall understanding of our ability to choose our life's direction. And deeper than all of that, the Gospel of Jesus Christ orients my personal worldview and sense of security, peace, hope, and love https://www.churchofjesuschrist.org/comeuntochrist/believe If you are in crisis, please contact the National Suicide Prevention Hotline at https://suicidepreventionlifeline.org or 1-800-273-TALK (8255) or your local emergency services. Copyright Therapy in a Nutshell, LLC

Thanks to our sponsor, Venice.AI. Get 20% off a pro plan using our link: venice.ai/coolstuff and code coolstuff. New ketamine study promises extended relief for depression The mystery of lightning may finally be solved Infrared contact lenses let people see in the dark – or with their eyes closed Apple's iPhone Update—Why You Need To Change Your Messaging App Contact the Show: coolstuffcommute@gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Learn more about new and emerging adjunctive treatments for major depressive disorder (MDD).  Credit available for this activity expires: 05/13/2026Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/new-and-emerging-adjunctive-treatments-major-depressive-2025a1000bbh?ecd=bdc_podcast_libsyn_mscpedu

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode is about counselling patients on antidepressant medications.Hosts: Matthew Cho and Angad SinghAudio editing: Angad SinghTime Stamps:2:03 - Steps to antidepressant counselling7:31 - Frequently asked questions about antidepressantsRelated Episodes:PsychEd Episode 1: Diagnosis of Depression with Dr. Ilana ShawnPsychEd Episode 2: Treatment of Depression with Dr. Sidney KennedyPsychEd Episode 58: Depression in Children and Adolescents with Dr. Darren CourtneyPatient Education:UpToDate resource on ‘Medicines for Depression': https://www.uptodate.com/contents/medicines-for-depression-the-basicsCAMH resource on ‘Antidepressant Medications':https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/antidepressant-medicationsKelty Mental Health resource on ‘Selective Serotonin Reuptake Inhibitors': https://keltymentalhealth.ca/sites/default/files/resources/SSRI_MedicationSheet2022.pdf, References:PsychDB. (2024, January 11). Introduction to Antidepressants. https://www.psychdb.com/meds/antidepressants/homeLam RW, Kennedy SH, Adams C, Bahji A, Beaulieu S, Bhat V, Blier P, Blumberger DM, Brietzke E, Chakrabarty T, Do A. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023: Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. The Canadian Journal of Psychiatry. 2024 Sep;69(9):641-87.Contact:For more about PsychEd follow us on Instagram (@psyched.podcast),  Facebook (PsychEd Podcast), and X (@psychedpodcast). You can email us at psychedpodcast@gmail.com and visit our website at psychedpodcast.org.

Q-BANK: https://patreon.com/highyieldfamilymedicineIntro (0:35),Major Depressive Disorder (1:57),Other mood disorders (7:50),Bipolar Disorder (12:58),Anxiety disorders (18:33),Psychotic disorders (25:36),Personality disorders (30:55),Psychiatric emergencies (36:36),Practice questions (42:24)

Feeling down from time to time is normal, but how can you tell when sadness is something more – like major depressive disorder? We spoke with Jessi Gold, MD, MS, the first chief wellness officer of the University of Tennessee system and bestselling author of How Do You Feel?, to unpack the complexities of depression. She breaks down the differences between temporary low mood and clinical depression, the role of genetics and medical conditions, and how daily stressors can contribute. We also dive into treatment options -- from therapy to medication -- and the importance of recognizing when it's time to seek help.

Today, The Frontier Psychatrists welcomes back my friend Ben Spielberg. He's been a reader for a long time and has contributed to the newsletter in the past. It was on Clinical Trial design, a perennial favorite around these parts.With only light edits, what follows is his work, narrated by me, for the Audio Version.I would invite you to the live class today on working as an out-of-network provider, but it sold out last night, so you'll have to wait for the next one. My prior article on Spravato is available here.The year is 2024. OpenAI has just launched its latest update to ChatGPT, promising more natural and less artificial-sounding language. Donald Trump has won the nomination for President of the United States. Another chain of ketamine clinics has engaged in a corporate reorganization. There is conflict in the Middle East. Are we sure that we're not living Groundhog's Day?I am the founder of Bespoke Treatment, an integrative mental health facility with multiple locations that has at times been referred to as a "ketamine clinic." I have also seen countless so-called "ketamine clinics" sell for pennies on the dollar and go bankrupt seemingly overnight. In this case, Numinus, a company that was publicly traded in Canada and owned a number of psychiatric clinics specializing in ketamine in the US and Canada, has sold its clinics to Stella (a company that has stealthily become one of the larger mental health providers in the country and is the first to bring the awesome SGB treatment to scale). It's not the first time this has happened. It's not the second, nor the third, nor even the fourth time this has happened. But yet, the common consensus is that ketamine clinics are a cheap, easy business with recurring revenue. So, what gives?Figure 1. A reddit user asking anesthesiologists if they should start a ketamine or Botox clinic for easy cash on the side. Does this make you feel gross? Should it?The Ketamine Clinic Model 101The most basic outline for a ketamine clinic is as follows: a provider rents an office space with, on average, five or so exam rooms. They buy equipment for infusions like a pump, catheter, needles, and syringes. They buy some comfortable recliner chairs. They hire a receptionist to answer phones, field patient questions, charge credit cards, and handle medical record requests. They hire a nurse to insert the IV, monitor vital signs, check blood pressure, juggle multiple patients at once, and make sure the ketamine is flowing into patients' veins unencumbered. Two SKUs are typically offered: ketamine infusions for mood, which last approximately 40 minutes, and ketamine infusions for pain, which last for up to 4 hours. Zofran is offered for nausea, and some clinics have fun add-ons like magnesium or NAD. An average mood infusion costs around $400-$500 in a medium cost-of-living area, while mood-infusions can run up to $700 in a higher cost-of-living area. Some clinics offer package discounts if patients buy six or more upfront, which helps with cash flow for the clinic (cash now is better than cash later, of course).A Note on Scope of PracticeThe first wave of ketamine clinics was started mainly by providers who were not mental health specialists. Instead, they were owned by anesthesiologists, ER physicians, and sometimes CRNAs. These providers were especially experienced with ketamine in hospital settings, as well as setting up infusions. Psychiatrists, on the other hand, do not usually order infusions in outpatient settings, and very few had actual hands-on experience with ketamine in practice. That being said, there are a number of variations to the model above: psychiatrist-owned ketamine clinics would often prefer to use intramuscular injections in lieu of infusions, but 2-3 injections would have to be given during a single session for mood and pain sessions were out of the question. Other ways to save costs might include having an EMT do the actual injections (this is highly state-dependent), asking nurses or MAs to work the front desk, or working a full-time regular doctor job. In contrast, your nurses run the actual ketamine services via standing orders, a written document that details routine and emergent instructions for the clinic.Some clinics offer full evaluations prior to rendering treatment, but many offer a simple brief screening on the phone to check for contraindications before scheduling a patient for their first session. The clinics owned by psychiatrists have historically been a bit more thorough in terms of the initial psychiatric evaluations, given that they can actually perform initial psychiatric evaluations within their respective scope of practice. Sometimes clinics may have therapists on-site who can render ketamine assisted therapy (meaning, therapy occurring concurrently) for an additional $100-$300. Otherwise, there is not much decision-making that goes on— other than deciding on medication dosages. Most infusions start off at .5mg/kg of body weight, which is by far the most evidence-based dosage. In practice, most clinics increase dosage every session because even though ketamine is considered to be a weight-based medicine for anesthesia, there is thought to be a “sweet spot” of dosage for everyone, if one can imagine an inverted U shape curved, where the ideal dosage for each patient is at the tippity-top of the inversion. Dosage increases are highly variable depending on the clinic: some have a maximum dosage, some will only increase a certain percentage, and some may even use standardized increments (e.g., only offering dosages in increments of 50mg). A typical series of infusions is 6-8 over 3-4 weeks, followed by boosters as needed.Fool's GoldAt first glance, the business model seems fantastic. As a cash business, there are no AR issues, no third party billing companies to deal with, and no prior authorizations to fight over. Sure, the cost is high, but it's not that high compared to many other healthcare services. Since the benefits fade over time, a ketamine clinic has built-in recurring revenue from patients every week, month, quarter, or year – it's like a subscription business! Ketamine is trendy and sexy; TV shows like White Lotus mention it, and ravers from the 90's recall it with great fondness. Unlike SSRIs and psychotherapy, ketamine works for depression fast. It's amongst the fastest treatments for depression that we have today, and there are a lot of depressed people. It can help someone out of debilitating depression in 40 minutes. It has none of the un-sexy side effects of SSRIs like sexual dysfunction, gastrointestinal discomfort, or uncontrollable sweating. Instead, it has sexy side effects: euphoria, hallucinations, and feelings of unity with the universe. Also, unlike SSRIs, it helps most people who try it. It really is an amazing treatment, and I often feel grateful that my clinic is able to offer it to patients in needFigure 2. Most business-savvy reddit user.Supply and Demand… or SomethingMood disorders disproportionately affect individuals who are of lower socioeconomic status compared to individuals with a lot of disposable income. Of course, wealthier individuals are no more immune to mental health disorders than anyone else, but the main target market that benefits most from ketamine just do not have the means to afford it. They don't have $3,000 to burn on yet another treatment that may or may not work. Often, the patients who could really use a series of ketamine infusions cannot scrounge enough money for a single infusion, let alone a whole series and prn boosters. However, there should be enough depressed people with cash to throw around out there… right?Wait, Isn't That A Horse Tranquilizer?Of course, ketamine clinics can find more patients via marketing and advertising. However, I've found that many medical doctors who see this population, like primary care providers, are not up to date with the research. When I first launched my company, I used to go door-to-door to medical buildings in Santa Monica with cookies to speak with them about advancements in interventional psychiatry. I cannot count the number of times that I was laughed out of each office; referring providers are risk-averse, and the perception of ketamine has traditionally been poor. Medical doctors would exclaim, “Of course people feel better; you're getting them high,” and lament that I was administering a drug thought to be highly addictive. Psychotherapists, who would also be fantastic referral partners, generally refer to psychiatry, but it's less common for them to refer to specific treatments. Nowadays, psychotherapists who are particularly invested in ketamine can sign up with venture-backed companies like Journey Clinical and render their own ketamine-assisted psychotherapy with some prescriber supervision. The issue is that despite the media attention, people with depression don't read innovative health newsletters, nor do they review papers in scientific journals. They rely on information from their psychiatrists, medication management providers, and psychotherapists. If they are not told that this is an option for them, they won't hear about it without ad spend. Oh yeah, and there is a major issue with ad spend: the word ketamine itself is a restricted drug term, and legitimate clinics routinely get banned from Google and Meta for mentioning it, which makes digital advertising more difficult than it would be for any other legitimate service.The Matthew Perry EffectKetamine is very desirable for some patients (unfortunately, sometimes the patients who want it most are frankly the worst candidates for it), but I'd wager that the majority of patients who need it are kind of scared of it. They want to feel good, they want relief from depression and trauma, but it's a weird thing to do a drug that is a horse tranquilizer and also an anesthetic in a reclining chair in a medical office that tricks your brain into feeling like you're dead for a little bit. It's kind of far off from acupuncture and more traditional alternative medicine. There is certainly a non-zero addictive potential that needs to be carefully weighed, it's not a particularly comfortable experience for many patients—especially those with a history of trauma—even if it helps after the experience is over. Additionally, the famous actor from the most famous show in the world, who was deemed to have a cause of death relating to ketamine, isn't exactly helping mass adoption. Overall, this just makes marketing and advertising even more expensive, because a) the majority of referring providers are skeptical, b) patients can't pay for it and c) patients who can pay for it are cautious.Disruptive Business ModelsIn the model I've described above, there are 3 sets of cost centers: rent, staff, and marketing. In some areas of the country, rent may be negligible, and in others, it is quite high. Like an owner-operated restaurant, if a clinic is owned by a company that is not a clinician, they have to find one and pay for one. Venture-backed companies like Mindbloom, Better U, and Joyous have also created entire businesses on the back of the COVID-era controlled substance waivers, whereby they send patients ketamine tablets and/or lozenges directly through the mail. Unlike the clinic model, they don't have rent to pay, and since national marketing campaigns are often cheaper than hyper-local brick and mortar campaigns, they are able to find new patients at lower acquisition costs compared to their clinic counterparts. Some patients do extensive research before treatment and only want to find IV clinics that offer specific dosages, but many are fine with the cheapest ketamine possible, and would prefer to pay as low as $150 for an entire month compared to $3,000.Figure 3. Did you sign up for a discounted ketamine subscription on Black Friday after purchasing a new flat-screen TV?Spravato: Coming In HotJohnson & Johnson's branded esketamine (note the prefix es) is on track to reach coveted “blockbuster status.” While it was FDA approved for Major Depressive Disorder in 2019, it took some time to catch on for a number of reasons including skepticism that the added es only added to pharma pockets and didn't actually work, health insurance companies taking time to decide on what their medical necessity criteria should be, and social isolation due to COVID-19 being a thing. My clinic has become one of the larger Spravato providers in the Los Angeles area, and while we still offer ketamine infusions, our infusion census has decreased by over 70%. The scenario is this: a patient with severe depression comes in to see us, they've heard about ketamine, but they find out that Spravato is covered by insurance for a $20 copay. Maybe ketamine has slightly better efficacy (which, in my opinion, is really just a function of being able to adjust dosage). Still, patients would prefer paying a lot less money to receive almost-the-same benefits.Death By A Thousand SticksThere are a number of other issues with the model that become problematic, especially at scale. Large medical distributors like McKesson and Henry Shein have instituted CYA policies, limiting ketamine sales to licensed anesthesiologists. Medical malpractice carriers alike have followed suit, requesting detailed addendums from providers regarding their ketamine training or flat-out refusing coverage for anyone who isn't an anesthesiologist. Since controlled substance manufacturing is directed by the DEA based on their own predictions, it's not uncommon for ketamine to go on shortage for weeks to months at a time. There are a myriad of problems with the model of point solutions which have been detailed here already, but in short, the old adage rings true: if all you have is a hammer, everything looks like a nail, and if all you have is ketamine, everything looks like a juicy vein. But while ketamine is a highly efficacious treatment, it's not the best treatment for everyone, and patients can become downright dysregulated after ketamine, which a clinic in this model just can't handle adequately at scale. And ultimately, methods to do everything cheaper don't work out that well. For example, putting multiple patients in one room may seem like a good idea, but it is ultimately not conducive to the actual ketamine experience. Any sort of vertical integration also adds an insurmountable amount of complexity, like starting to offer Spravato or TMS, because now they have to start accepting insurance, become in-network, manage billing and AR, and so on. Depending on location and the clinic set-up, they also require specialized providers onsite.Figure 4. Supply chain issues abound.Insurance IssuesSome patients try to be well-informed. They, rightly or otherwise, don't believe everything they hear from their providers, so they call up their health insurance companies and ask. They just call the phone number on the back of the card and ask the representative if ketamine infusions are covered. Undoubtedly, the representative says yes—even though many insurance companies have published guidelines that explicitly deny any coverage for ketamine for a mental health disorder. These patients come in frustrated, distrustful of their providers and reaffirms their belief that ketamine clinics are just cash grabs. Even if one manages to obtain a coveted insurance contract for ketamine, like Ketamine Wellness Centers had with the VA, it kickstarts cashflow and complexity issues that scale should sort out, but ultimately doesn't because of the aforementioned issues above.Overall, it is possible to have a successful ketamine clinic in 2024. Still, it isn't easy due to market conditions, the population served, and the ever-changing landscape of mental health treatment. While many successful clinics exist today, the wheels tend to start to fall off when scaling, where all of a sudden, a clinic's reach has surpassed its captive population. Otherwise, it becomes a series of continual cost-cutting until there is nothing left to cut… save for the business itself.Ben Spielberg is the Founder and Chief Executive Officer of Bespoke Treatment, a comprehensive mental health facility with offices in Los Angeles, CA, and Las Vegas, NV. He is also a PhD Candidate in Cognitive Neuroscience at Maastricht University.For more on psychiatric medications, buy my book Inessential Pharmacology. (amazon link).For pieces by other TFP contributors, follow:Alex Mendelsohn, Michelle Bernabe, RN, @Psych Fox, Carlene MacMillan, MD, David Carreon, M.D., Benjamin Lippmann, DO, Awais Aftab, Courtny Hopen BSN, HNB-BC, CRRN, Leon Macfayden and many others! The Frontier Psychiatrists is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit thefrontierpsychiatrists.substack.com/subscribe

Credits: 0.50 AMA PRA Category 1 Credit™, 0.50 ABIM MOC or 0.41 AANP, including 0.41 AANP Pharm   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/when-ssris-are-not-enough  Overview: In this podcast, expert faculty will discuss how the heterogeneity of major depressive disorder (MDD) symptoms, the frequency of residual symptoms, and the common occurrence of treatment-resistant depression (TRD) indicate a pathophysiology that is complex and multifactorial. The faculty will provide an overview of the current understanding of MDD pathophysiology and discuss how current standard-of-care treatments often fail to comprehensively target these mechanisms, emphasizing how future treatment developments can focus on under-addressed pathophysiological mechanisms, paving the way for personalized MDD treatments that target individual symptom profiles. 

In this highly anticipated follow-up, we welcome back Jon Nelson, the man who went from battling relentless, treatment-resistant depression to becoming a pioneering advocate for mental health. Jon's journey with deep brain stimulation (DBS) wasn't just a breakthrough; it was a total game-changer. Now, with “robots in his head” pumping 23 million pulses a day, Jon's mission has evolved from mere survival to a full-throttle campaign to ‘Pulverize the Stigma.' We delve into the shocking realities of stigma, outdated treatments, the price of mental illness on families, and how a bold middle finger to societal norms is long overdue.SHOW NOTESIntroduction: Matt recaps Jon's #1 episode, "Robots in My Head," and introduces Jon's latest campaign, "Pulverize the Stigma."The Fight Continues: Jon discusses the post-DBS journey and why stigma remains a public health crisis.From Suicidal Ideation to Mission Mode: Jon shares his transformation from survival to advocacy, fueled by the urgency to make people understand mental illness as a brain disease.Systemic Failures: They tackle the stigma, the lack of insurance support, and how recent government funding cuts to mental health research could set progress back decades.The Reality of Stigma: Jon paints a visceral picture of what it's like to live with depression and how society's dismissive attitude does real harm.Empathy as a Cure: The impact of compassion, kindness, and simple human gestures—why they can be more effective than therapy or meds.Final Thoughts and Resources: Jon offers powerful calls to action and provides resources for listeners, including his new site, PulverizeTheStigma.com, and the nonprofit One Mind.RELATED LINKSJon's First Episode: "Robots In My Head: Deep Brain Stimulation"Jon's Website"Jon Nelson: Five Things I Wish Someone Told Me When I Was First Diagnosed With Mental Illness""Today's Depression Treatments Don't Help Everyone""#37: Jon Nelson – DBS for Depression Saved My Life: Defying Stigma in Mental Health"See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Did you know, there is a physical transfer of energy when sunlight hits our bodies? Without light, there is no life! On this episode of Vitality Radio, Jared welcomes back Suzanne Bates, one of our own at Vitality Nutrition. Previously she told her story about how she reversed her own heart failure, diabetes, severe depression and more using natural means. Here Suzanne shares her experience challenging herself to 100 Days of Light and what role that played in her healing journey. She and Jared discuss the incredible benefits of sunlight on mental and physical health. You'll also learn how to incorporate stillness, gratitude, and grounding into a sunlight practice and how to challenge yourself the way Suzanne did and see big changes in your own life!Challenge:*Every day in October, go outside at sunrise for 15-30 minutes! *Look up towards the brighter part of the sky for 10 seconds (Never look directly at the sun!)*Attempt to be still for 5-10 minutes*Incorporate the practice of gratitudeShare your experiences and gain support by becoming part of the Facebook community:Get Up! Get Out! Get Happy! Additional Information:#442: Against the Odds - A Story of Hope and Healing with Suzanne Bates#378: Emotional Vitality: Using Curiosity to Take Back Control of Your Subconscious MindGet Up! Get Out! Get Happy! - Facebook groupVisit the podcast website here: VitalityRadio.comYou can follow @vitalityradio and @vitalitynutritionbountiful on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Please also join us on the Dearly Discarded Podcast with Jared St. Clair.Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

Abby and Patrick welcome labor journalist Sarah Jaffe – author of Necessary Trouble and Work Won't Love You Back – for her first interview about her forthcoming book, From the Ashes: Grief and Revolution in a World on Fire. From the Ashes is at once a deeply personal narrative and a wide-ranging journey of searing reportage on the lives and struggles of individuals and communities. Sarah, Abby, and Patrick take on the overdeterminations of loss, grief, mourning, and memorialization from contemporary political discourse to Freud's classic “Mourning and Melancholia.” In what ways can individual experiences of grief be fundamentally singular and yet also sites of collective solidarity and social transformation? What are the norms, narratives, and timelines that get imposed on expressions of psychic pain in the wake of loss, from the DSM to Human Resources to newspaper headlines? How does the experience of loss differ when the lost object in question isn't necessarily a person, but a place, an ideal, intergenerational links, or expectations for a now-foreclosed future instead?Details about From the Ashes are here: https://www.hachettebookgroup.com/titles/sarah-jaffe/from-the-ashes/9781541703490/ and the book is available for preorder here: https://hachettebookgroup.formstack.com/forms/fromtheashes (use code FTA20 for 20% off, plus bonus content)Sarah's website is here: https://sarahljaffe.com/Key texts cited in the episode:Freud, “Mourning and Melancholia”Freud, “On Transience”Jacqueline Rose, “Virginia Woolf and the Death of Modernism”Namwali Serpell, The FurrowsHave you noticed that Freud is back? Got questions about psychoanalysis? Or maybe you've traversed the fantasy and lived to tell the tale? Leave us a voicemail! 484 775-0107  A podcast about psychoanalysis, politics, pop culture, and the ways we suffer now. New episodes on Saturdays. Follow us on social media:  Linktree: https://linktr.ee/OrdinaryUnhappiness Twitter: @UnhappinessPod Instagram: @OrdinaryUnhappiness Patreon: patreon.com/OrdinaryUnhappiness Theme song: Formal Chicken - Gnossienne No. 1 https://open.spotify.com/album/2MIIYnbyLqriV3vrpUTxxO Provided by Fruits Music

In this episode, we review the high-yield topic of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Major Depressive Disorder ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Psychiatry section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets Linkedin: https://www.linkedin.com/company/medbullets

In this episode Dr. Lyon sits down with Dr. Erik Won, President and Chief Medical Officer of WAVE Neuroscience Biotechnology. Dr. Won shares his journey from being a Navy flight surgeon to leading groundbreaking research in brain health. If you struggle with brain fog, depression, PTSD, or traumatic brain injury, this episode is for you. Learn about innovative treatments that are changing lives and providing hope for those suffering from brain-related conditions. Don't miss this enlightening conversation on the future of neuroscience!Dr. Erik Won is President and Chief Medical Officer of Wave Neuroscience, Inc; a biotechnology company that has innovated breakthrough technologies called Magnetic e-Resonance Therapy (MeRT) and Synchronized Transcranial Magnetic Stimulation (sTMS). These technologies utilize computational neuroanalytics and brain imaging to customize treatment protocols with the aim of restoring optimal neurological function. These modalities represent a form of precision-guided medicine that has been researched or is currently being used by premier institutions such as US Special Operations Command, Stanford University School of Medicine, Duke University - Human Performance Opti-Lab, University of Southern California (USC) Center for Neurorestoration, the University of California Los Angeles (UCLA) - David Geffen School of Medicine, University of Pennsylvania, Brown University, and the Texas A&M Institute for Bioscience and Technology, among others. Erik joined Wave Neuroscience after serving as the Chief Physician and Chief Technology Officer (Health Services) for the Boeing Company. He also served as a US Navy Flight Surgeon for Marine Medium Helicopter Squadron 268, and received the distinction of serving as the ACE Flight Surgeon for the 11th Marine Expeditionary Unit, 1st Marine Expeditionary Force. Dr. Won has been published in numerous peer-reviewed journals, textbooks, and presented in numerous academic conferences. He completed his residency at the Harvard OEM combined residency program and was appointed Chief Resident. He received a Masters in Public Health (MPH) from the Harvard School of Public Health and Masters in Business Administrations (MBA) from the University of Southern California, Marshall School of Business.

What do you do when you find yourself on 14 prescription medications and your health is only declining? On this episode of Vitality Radio, Jared interviews Suzanne Bates, one of our own at Vitality Nutrition. She shares her story of taking her health into her own hands when western medicine failed her. Suzanne was an ICU nurse and believed wholeheartedly in the ways of western medicine, until she realized it wasn't helping her at all. You'll hear how she went from almost bedridden with multiple diagnoses and drugs for all of them, to vibrant and healthy, no longer burdened with those illnesses, and down to one prescription which is on its way out. She shares the incredible story of how she was led to Vitality Nutrition and the one supplement that started her on a journey to natural healing and a life full of hope and joy.Products:N.O. Cardio BoostSunChlorella ChlorophyllBerberineAlpha Lipoic AcidSuntheanineTri-IodineRhodiolaAdditional Information:#264: Emotional Vitality: Jen's Story Part 1 - From Addiction and Mental Illness to VitalityVisit the podcast website here: VitalityRadio.comYou can follow @vitalityradio and @vitalitynutritionbountiful on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Please also join us on the Dearly Discarded Podcast with Jared St. Clair.Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

Ask Kati Anything, your mental health podcast episode 217 | This week licensed therapist Kati Morton talks about getting past inner resistance in therapy, how to keep going when we feel like giving up, and what a therapist would do if their client is intellectualizing everything. She then explains what a body memory is and why our trauma memories can be so spotty. Finally, she discusses anxiety about making phone calls, and why we can be so worried about every little thing we do, and believe that people are going to think we are weird. Audience questions: 1. Could you possibly talk about getting past inner resistance in therapy? I've been in therapy for about 8 months and feel like we've done some amazing work, but have noticed I'm hitting some type of wall within myself that I'm not sure how to get past. It's like I've kind of traveled through all the issues I've been conscious of, but now that we're deeper in I'm realizing there's a lot going on that I was not aware of... 01:14 2. Hi Kati. How do I keep going? I feel like giving up. I have Major Depressive Disorder. Suicidal thoughts and self injury consume me. I've done talk therapy, CBT, DBT, ACT, TMS, and ECT. Nothing has helped. I've been hospitalized twice. I've been on so many medications I can't keep track anymore. I feel so alone in this. I do have a psychiatrist, therapist and loving family but they don't understand... 09:54 3. I was wondering how a therapist would approach working with a client who intellectualizes everything? I find CBT and DBT unhelpful because everything my therapist is saying, while totally true, I've already known about and pieced together myself. I think that's also where I get so stuck with therapy- I KNOW there are these pieces out of place that aren't serving me. I KNOW why I am the way I am, but I don't know what to do about it? 24:54 4. I saw one of your older videos about people not remembering their trauma or remembering it in patches but I'm the opposite, I remember what happened to me in great detail even down to what I was wearing, what they were wearing the day and time everything. The only problem I do have is deciding if what actually happened to me was SA... 33:17 5. I noticed recently that I'm really scared to call people I haven't spoken to in a long time. I know they'd love to hear from me and vice versa if they called me. So what's the hang-up (pun intended)? How do I reduce my anxiety around it? It's just literally a fear of pressing call and waiting while the phone rings. I'm not actually scared to talk to these people. What's that about? How do I make pressing the button or the waiting time while the phone rings before they pick up easier? How do I select who to call? Are there steps I can take to get to that point? 42:46 6. Hey Kati what is it called when you are so concerned with the way you walk, blink , eat, move your mouth when you talk, ect. I feel like I walk weird, and I talk weird. I feel like I'm insecure about my voice being too deep or my laugh being too loud. Just little everyday things. I never hear about this. 46:26 PUBLISHED BOOKS ⁠⁠⁠⁠⁠⁠Traumatized⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠Are u ok?⁠⁠⁠⁠⁠⁠ A great way to support my channel is to visit our sponsors by using these links: ⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠Instacart⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠ONLINE THERAPY⁠⁠⁠⁠⁠⁠ While I do not currently offer online therapy, BetterHelp can connect you with a licensed, online therapist: ⁠⁠⁠⁠⁠⁠https://betterhelp.com/kati⁠⁠⁠⁠⁠⁠ (enjoy 10% off your first month) SOCIAL ⁠⁠⁠⁠⁠⁠X⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠Pinterest⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠Patreon⁠⁠⁠⁠⁠⁠ PARTNERSHIPS Linnea Toney linnea@underscoretalent.com --- Send in a voice message: https://podcasters.spotify.com/pod/show/askkatianything/message Support this podcast: https://podcasters.spotify.com/pod/show/askkatianything/support

A huge problem with current psychiatric diagnosis is that it often lumps completely unrelated things under the same vast and vague tent, such as with the diagnosis of "Major Depressive Disorder".   Here Craig sits down with his patient Rebecca to try to make sense of her complex early onset depression and how it played out via addiction, anorexia, and pathological caretaking and how she was finally able find the grace and compassion to prioritize care for herself.Bringing Therapy into Med Management-- An intensive psychotherapy training in Colorado with Dr.  Hhttps://www.craigheacockmd.com/training/BFTA on IG @backfromtheabysspodcasthttps://www.instagram.com/backfromtheabysspodcast/BFTA/ Dr. Hhttps://www.craigheacockmd.com/podcast-page/

In a shocking case of senseless violence, 19-year-old Brian Cohee II brutally murders and dismembers a homeless man, Warren Barnes, in Grand Junction, Colorado, leaving the community questioning the killer's sanity and motive as disturbing details of his past and the gruesome crime come to light during a high-profile trial. Subscribe on your favorite podcasting apps: https://talkmurder.com/subscribeSupport us on patreon: https://patreon.com/talkmurderSee our technology: https://talkmurder.com/gearContent warning: the true crime stories discussed on this podcast can involve graphic and disturbing subject matter. Listener discretion is strongly advised.Fair use disclaimer: some materials used in this work are included under the fair use doctrine for educational purposes. Any copyrighted materials are owned by their respective copyright holders. Questions regarding use of copyrighted materials may be directed to legal [@] Talkocast.com

Today, you'll learn about the surprising effect our immune system has on our emotional health, a new discovery about the biological clock of plants, and how researchers are rediscovering the science of psychedelics. Stress & Immunity “Mount Sinai Study Shows That Circulating Immune Cells Drawn to the Brain During Stress Can Control Emotional Behaviors.” Mt. Sinai. 2024. “Major Depressive Disorder.” by Navneet Bains & Sara Abdijadid. 2023. “Circulating myeloid-derived MMP8 in stress susceptibility and depression.” by Flurin Cathomas, et al. 2024. Crop Resilience “USC researchers uncover biological circuit that protects plants from extreme conditions.” EurekAlert! 2024. “Climate Change Impacts on Agriculture and Food Supply.” EPA. 2023. “The interplay between the circadian clock and abiotic stress responses mediated by ABF3 and CCA1/LHY.” by Tong Liang, et al. 2024. Psychedelic Scale “An intriguing psychedelic assessment is back from the dead, thanks to Swiss scientists.” by Eric W. Dolan. 2024. “The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences.” by Tomas Frymann, et al. 2022. “The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.” by Kurt Stocker, et al. 2023. Follow Curiosity Daily on your favorite podcast app to get smarter with Calli and Nate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers. Hosted on Acast. See acast.com/privacy for more information.

What is depression? Neil deGrasse Tyson and co-hosts Chuck Nice and Gary O'Reilly break down the neuroscience behind major depression, its treatments, and the factors that contribute to this pervasive condition with neuroscientist Heather Berlin, PhD.NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free here: https://startalkmedia.com/show/why-we-get-depressed-with-heather-berlin/Thanks to our Patrons Geoff Malone, Neander Rowlett, Brial Teel, Baran Blaser, Maxwell Miller, Doug Litwin, and Edward Bally for supporting us this week.